Your partner from bench to clinic
Leveraging our proprietary product portfolio and development platforms we co-create customised products to our partners’ specification.
In addition, by maintaining control over manufacturing and intellectual property of products developed through our in-house platform, our partner’s products benefit from long term patent-protection and access to consistent and high-quality reagents and tools.
High-quality proteomic tools including antibodies, assays, engineered cell lines, available at scale
Leverage our innovative discovery platforms and manufacturing expertise to enable the co-creation of new precision reagents
Reagent discovery, development, formulation and manufacturing and project management
Strong product IP protection ensuring a proprietary position
Global sales and commercialization channel to support accelerated market acceptance of promising products
Abcam has several key areas of interest where we are looking for partnerships:
Commercial partnerships to advance diagnostic and therapeutic discovery
We are interested in partnering with companies or organisations developing either novel clinical or instrument platforms or upgrading their existing platforms to address novel biomarkers. Abcam will help these partners develop the right content, such as antibodies and other protein reagents or assays, to meet the demanding needs of their users.
Product and technology partnerships
As we strive to provide the highest quality and most relevant antibodies to researchers around the world, we are seeking opportunities to in-license certain assets to directly expand our portfolio. Furthermore, we are searching for partnerships to enhance our recombinant antibody development capabilities.
Specifically we are seeking the following:
Where there is an immediate, mutually beneficial commercial opportunity, we also invest in early stage companies, and university spin outs developing technologies in the following areas: